Bmc Complementary And Alternative Medicine SCIE

國(guó)際簡(jiǎn)稱：BMC COMPLEM ALTERN M 參考譯名：Bmc 補(bǔ)充和替代醫(yī)學(xué)

主要研究方向：INTEGRATIVE & COMPLEMENTARY MEDICINE 非預(yù)警期刊審稿周期：一般,3-6周

《Bmc 補(bǔ)充和替代醫(yī)學(xué)》(Bmc Complementary And Alternative Medicine)是一本由BioMed Central出版的以INTEGRATIVE & COMPLEMENTARY MEDICINE為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù)，影響因子不斷增加，發(fā)行量也同樣高。

2區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
0 年發(fā)文量
開放是否OA
72 H-index
2001 創(chuàng)刊年份
Irregular 出版周期
English 出版語(yǔ)言

BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation.

[ 查看全部 ]

投稿咨詢加急咨詢

Bmc Complementary And Alternative Medicine期刊信息

ISSN：1472-6882
出版語(yǔ)言：English
是否OA：開放
E-ISSN：2662-7671
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：BioMed Central
出版周期：Irregular
創(chuàng)刊時(shí)間：2001
開源占比：1
Gold OA文章占比：100.00%
OA被引用占比：
出版國(guó)人文章占比：0
出版撤稿占比：
研究類文章占比：0.00%

Bmc Complementary And Alternative Medicine CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

6.1

0.673

1.08

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Complementary and Alternative Medicine	Q1	18 / 105	83%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Bmc Complementary And Alternative Medicine中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科醫(yī)學(xué)與補(bǔ)充醫(yī)學(xué)	2區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科醫(yī)學(xué)與補(bǔ)充醫(yī)學(xué)	2區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科醫(yī)學(xué)與補(bǔ)充醫(yī)學(xué)	2區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科醫(yī)學(xué)與補(bǔ)充醫(yī)學(xué)	2區(qū)

Bmc Complementary And Alternative Medicine JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位

Bmc Complementary And Alternative Medicine歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Bmc Complementary And Alternative Medicine中國(guó)學(xué)者發(fā)文選摘

1、Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy
Author: Cai, Weiye; Sun, Bin; Song, Chao; Liu, Fei; Wu, Zhengliang; Liu, Zongchao

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03943-8
2、Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
Author: Jiang, Yunzhong; Zhang, Mengzhao; Wang, Lu; Zhang, Lu; Ma, Minghai; Jing, Minxuan; Li, Jianpeng; Song, Rundong; Zhang, Yuanquan; Yang, Zezhong; Zhang, Yaodong; Pu, Yuanchun; Qu, Xiaowei; Fan, Jinhai

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03938-5
3、Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation
Author: Fan, Zhu; Wang, Shuxin; Xu, Chenchen; Yang, Jiao; Cui, Bingnan

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03960-7
4、Panax quinquefolius saponin inhibits vascular smooth muscle cell calcification via activation of nuclear factor-erythroid 2-related factor 2
Author: Lu, Xiaoting; Liu, Xue; Liang, Ershun; Yang, Ruixue; Liu, Yan; Liu, Xiaoqiong; Yan, Fangfang; Xing, Yifan

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03961-6
5、Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells
Author: Huang, Le-Tian; Li, Tie-Jun; Li, Ming-Lin; Luo, Han-Yong; Wang, Yi-Bing; Wang, Jia-He

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03944-7
6、Oxymatrine ameliorates myocardial injury by inhibiting oxidative stress and apoptosis via the Nrf2/HO-1 and JAK/STAT pathways in type 2 diabetic rats
Author: Huang, Yongpan; He, Bin; Song, Chong; Long, Xian; He, Jianbin; Huang, Yansong; Liu, Lijing

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-022-03818-4
7、Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology
Author: Wang, Sutong; Ji, Tianshu; Wang, Lin; Qu, Yiwei; Wang, Xinhui; Wang, Wenting; Lv, Mujie; Wang, Yongcheng; Li, Xiao; Jiang, Ping

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-022-03826-4
8、Costs of traditional Chinese medicine treatment for inpatients with lung cancer in China: a national study
Author: Nie, Hanlin; Han, Zhaoran; Nicholas, Stephen; Maitland, Elizabeth; Huang, Zhengwei; Chen, Sisi; Tuo, Zegui; Ma, Yong; Shi, Xuefeng

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-022-03819-3